Tue, Mar 05, 2024
Suven Pharma share price, Suven Pharma news: Suven Pharmaceuticals (SUVENPHAR) shares retreated from a two-month high touched this week after the Hyderabad-based pharma company announced the merger of contract development and manufacturing organisation (CDMO) and merchant API platform provider Cohance Lifesciences with itself. Here's how analysts view the Suven-Cohance merger.
More >
Fri, Mar 01, 2024
Cohance Lifesciences will merge with Suven Pharma, the board approved the merger of Cohance Lifesciences... Suven will get 11 shares in exchange for 295 shares of Cohance.
At around 10:00 a.m., shares of Suven Pharmaceuticals traded 10.10 per cent or Rs 63.7, higher at Rs 694.6 apiece. The market capitalisation of the company at around the same time stood at Rs 17,852.64 crore.
Wed, Sep 13, 2023
The proposal, evaluated by regulators and relevant agencies including SEBI, the RBI and the CCI, is subject to the fulfillment of applicable rules and regulations.
Big news for Suven Pharma, news quoting sources, discussion on approval of FDI in Suven Pharma in CCEA, possible approval to sell 76% stake to Cyprus company Berhyanda.
Mon, Dec 26, 2022
According to a PTI report, the acquisition is pegged at Rs 6,300 crore and that Advent had pipped rival Blackstone for the acquisition.
Mon, Dec 12, 2022
The report said that promoters were earlier planning to sell only 30 per cent stake but now they are ready to sell the entire holdings as they are getting good valuation.
There is big news coming in for Suven Pharma. Promoters are planning to sell stake. Talks are underway with multiple PE investors. Blackstone interested in buying Advent stake. Know the full news from Swati Khandelwal.
Tue, May 17, 2022
CDMO Pharma revenue share 57%... set to introduce 15 new products in FY23... target 40% higher revenue in coming quarters: Venkat Jasti, MD, Suven Pharma.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
